Skip to main content
glpverdict
Editorial medical reviewFDA & peer-reviewed sourcesUpdated weeklyMedically reviewed content
HomeCompareOzempic vs Wegovy HD

Medication comparison

Ozempic vs Wegovy HD

Ozempic and Wegovy HD are both GLP-1 receptor agonist medications used for Type 2 diabetes (Ozempic) and Chronic weight management (BMI >=30, or >=27 with at least one weight-related comorbidity). The table below compares FDA-approved indications, dosing, weight-loss outcomes, side effects, contraindications, and current pricing — all sourced from the manufacturer prescribing information.

Find a provider for Ozempic or Wegovy HD

Affiliate disclosure: we earn commission on signups. Editorial ranking stays independent.

This is general drug information, not medical advice. Talk to a licensed clinician before starting, stopping, or switching medication.

Overview

PropertyOzempicWegovy HD
Generic namesemaglutidesemaglutide 7.2 mg
Drug classGLP-1 receptor agonistGLP-1 receptor agonist
ManufacturerNovo NordiskNovo Nordisk
Brand namesOzempic, Wegovy, RybelsusWegovy HD

Approved uses

PropertyOzempicWegovy HD
Approved indicationsType 2 diabetes (Ozempic), Chronic weight management (Wegovy)Chronic weight management (BMI >=30, or >=27 with at least one weight-related comorbidity)

Dosing

PropertyOzempicWegovy HD
Typical dosingTitrate to 2.4 mg (weekly SC injection)Titrate to 7.2 mg (weekly SC injection)

Side effects & warnings

PropertyOzempicWegovy HD
Top side effectsNausea (44.2%), Diarrhea (31.5%), Vomiting (24.8%)Nausea (common), Vomiting (common), Diarrhea (common)
ContraindicationsPersonal or family history of medullary thyroid carcinoma (MTC); Multiple endocrine neoplasia syndrome type 2 (MEN 2); Hypersensitivity to semaglutide or any product component
Boxed warningYesYes

Special populations

PropertyOzempicWegovy HD
PregnancyC — Discontinue at least 2 months before a planned pregnancy due to long half-life.Discontinue >=2 months before planned pregnancy

Storage

PropertyOzempicWegovy HD
StorageRefrigerate 36-46°F (2-8°C) before first use. After first use, may be stored at room temperature 59-86°F (15-30°C) for up to 56 days. Protect from light. Do not freeze.Refrigerate 2-8 C unopened. After first use: room temp up to 28 days.

Cost

PropertyOzempicWegovy HD
Avg monthly cost$997.58$1349.00

FDA boxed warning

Ozempic: Risk of thyroid C-cell tumors. Contraindicated in patients with personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).

Wegovy HD: Not established in humans, rodent C-cell tumor signal only; human relevance unknown per FDA label. Contraindicated in patients with personal or family history of medullary thyroid carcinoma (MTC) or MEN 2.

Frequently asked

What is the difference between Ozempic and Wegovy HD?

Ozempic is semaglutide (GLP-1 receptor agonist) and Wegovy HD is semaglutide 7.2 mg (GLP-1 receptor agonist). They have different active ingredients and slightly different side-effect profiles.

Is Ozempic or Wegovy HD more effective for weight loss?

See each drug's clinical-trials section for the registrational outcome data (SURMOUNT for tirzepatide; STEP for semaglutide; SCALE for liraglutide). Average weight loss varies by trial duration, dose ceiling, and adherence.

Can I switch between Ozempic and Wegovy HD?

Switching between GLP-1 medications requires re-titration when crossing active ingredients (semaglutide ↔ tirzepatide). Always coordinate with your prescriber before switching.

Other GLP-1 head-to-head comparisons

More medication context

Tools and guides that pair with this comparison.

Affiliate disclosure: we earn commissions when readers sign up through our links. Editorial ranking is independent.